Helicobacter pylori vaccine - AstraZeneca/CSL
Latest Information Update: 02 Oct 2021
At a glance
- Originator CSL
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 17 Oct 2001 Discontinued-Preclinical for Helicobacter infections in Australia (PO)
- 17 Oct 2001 Discontinued-Preclinical for Helicobacter infections in USA (PO)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed